21st Century Oncology Participates in Groundbreaking Studies on Breast Cancer Treatment
Constantine Mantz, M.D., chief medical officer at 21st Century Oncology, is one of 12 physicians who recently presented studies about an advanced therapy for breast cancer treatment at two national medical conferences. The studies demonstrated the cosmetic advantages and precise radiation capabilities of the SAVI® breast brachytherapy applicator for treatment of early-stage breast cancer.
Fort Myers, FL, March 29, 2012 --(PR.com)-- Constantine Mantz, M.D., chief medical officer at 21st Century Oncology, is one of 12 physicians who recently presented studies about an advanced therapy for breast cancer treatment at two national medical conferences. The studies demonstrated the cosmetic advantages and precise radiation capabilities of the SAVI® breast brachytherapy applicator for treatment of early-stage breast cancer.
21st Century Oncology is one of 12 centers in the U.S. participating in the SAVI Collaborative Research Group and contributing to ongoing research into the SAVI applicator.
Dr. Constantine Mantz has been heavily involved in the research project, “SAVI treatment is used in conjunction with breast conservation therapy; where the tumor and surrounding tissue are removed, and the surgery is followed with a course of radiation. Traditionally, that radiation treatment is delivered five days a week for six weeks following surgery and the entire breast is radiated. With SAVI, the radiation is delivered far more precisely and over a course of just 5-days.”
The SAVI device is the only single-entry breast brachytherapy device that allows physicians to sculpt radiation based on patient-specific anatomy, which increases the number of women who can benefit from accelerated partial breast irradiation (APBI).
The studies reached two primary conclusions:
1) SAVI radiation therapy provides for excellent or good cosmetic outcomes in the majority of patients.
2) The device can safely and effectively treat the broadest range of women through APBI, due to the precision with which the SAVI applicator can deliver the dose.
In a scientific poster presented at the National Interdisciplinary Breast Center Conference, researchers examined cosmetic outcomes with the device among a group of 1,010 patients. Researchers found highly favorable outcomes with regard to cosmetic results.
The second scientific poster was presented at the annual meeting of the American College of Radiation Oncology. It examined elements of radiation dosimetry with the SAVI device among 817 patients, and demonstrated the device's ability to precisely deliver radiation.
About 21st Century Oncology
Headquartered in Fort Myers, 21st Century Oncology, LLC. is a leading developer and operator of radiation therapy centers in the U.S. For 30 years, 21st Century Oncology has been committed to providing premier, quality, cost-effective radiation therapy services that are responsive to the needs of its patients through continuous improvement and innovation. The company employs over 113 radiation oncologists and over 138 specialists, including 84 urologists, 28 surgeons, 15 medical oncologists, 3 pathologists, 4 gynecologic oncologists and 4 primary care physicians. They operate 94 facilities in 16 states in the USA with another 27 internationally for a total of 121 facilities.
For further information, contact:
Sherri Kubesh, 239-839-6015 cell, or skubesh@rtsx.com
21st Century Oncology is one of 12 centers in the U.S. participating in the SAVI Collaborative Research Group and contributing to ongoing research into the SAVI applicator.
Dr. Constantine Mantz has been heavily involved in the research project, “SAVI treatment is used in conjunction with breast conservation therapy; where the tumor and surrounding tissue are removed, and the surgery is followed with a course of radiation. Traditionally, that radiation treatment is delivered five days a week for six weeks following surgery and the entire breast is radiated. With SAVI, the radiation is delivered far more precisely and over a course of just 5-days.”
The SAVI device is the only single-entry breast brachytherapy device that allows physicians to sculpt radiation based on patient-specific anatomy, which increases the number of women who can benefit from accelerated partial breast irradiation (APBI).
The studies reached two primary conclusions:
1) SAVI radiation therapy provides for excellent or good cosmetic outcomes in the majority of patients.
2) The device can safely and effectively treat the broadest range of women through APBI, due to the precision with which the SAVI applicator can deliver the dose.
In a scientific poster presented at the National Interdisciplinary Breast Center Conference, researchers examined cosmetic outcomes with the device among a group of 1,010 patients. Researchers found highly favorable outcomes with regard to cosmetic results.
The second scientific poster was presented at the annual meeting of the American College of Radiation Oncology. It examined elements of radiation dosimetry with the SAVI device among 817 patients, and demonstrated the device's ability to precisely deliver radiation.
About 21st Century Oncology
Headquartered in Fort Myers, 21st Century Oncology, LLC. is a leading developer and operator of radiation therapy centers in the U.S. For 30 years, 21st Century Oncology has been committed to providing premier, quality, cost-effective radiation therapy services that are responsive to the needs of its patients through continuous improvement and innovation. The company employs over 113 radiation oncologists and over 138 specialists, including 84 urologists, 28 surgeons, 15 medical oncologists, 3 pathologists, 4 gynecologic oncologists and 4 primary care physicians. They operate 94 facilities in 16 states in the USA with another 27 internationally for a total of 121 facilities.
For further information, contact:
Sherri Kubesh, 239-839-6015 cell, or skubesh@rtsx.com
Contact
21st Century Oncology
Carolyn Rogers
239-278-3900
Carolyn Rogers
239-278-3900
Contact
Categories